Tau-targeting therapies for Alzheimer disease: current status and future directionsErin E. Congdon, Einar M. Sigurdsson|Nature Reviews Neurology|2023Cited by 309
Single-domain antibody–based noninvasive in vivo imaging of α-synuclein or tau pathologyYixiang Jiang, Einar M. Sigurdsson|Science Advances|2023Cited by 36
Dynamic assessment of tau immunotherapies in the brains of live animals by two-photon imagingQian Wu, Einar M. Sigurdsson|EBioMedicine|2018Cited by 35
Single-domain antibody-based protein degrader for synucleinopathiesYixiang Jiang, Einar M. Sigurdsson|Molecular Neurodegeneration|2024Cited by 12
Anti-tau single domain antibodies clear pathological tau and attenuate its toxicity and related functional defectsSudershana Nair, Einar M. Sigurdsson|Cell Death and Disease|2024Cited by 7